{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:36Z","timestamp":1793725836307,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00405-025-09540-4","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T16:13:49Z","timestamp":1752336829000},"page":"4097-4107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study"],"prefix":"10.1007","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1831-4406","authenticated-orcid":false,"given":"Govoni","family":"Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1082-6598","authenticated-orcid":false,"given":"Soncini","family":"Arianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-2872","authenticated-orcid":false,"given":"Cuda","family":"Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oretti","family":"Gabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazio Maria","family":"Silvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-9478","authenticated-orcid":false,"given":"Zambonini","family":"Giulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-895X","authenticated-orcid":false,"given":"Ugolini","family":"Sara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Irene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carpentiero Colarusso","family":"Celeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaci","family":"Enrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasanisi","family":"Enrico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salsi","family":"Daria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"Suppl S29","key":"9540_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"issue":"9","key":"9540_CR2","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamaoto.2020.1453","volume":"146","author":"JW Grayson","year":"2020","unstructured":"Grayson JW, Hopkins C, Mori E, Senior B, Harvey RJ (2020) Contemporary classification of chronic rhinosinusitis beyond polyps vs no polyps: A review. JAMA Otolaryngol Neck Surg 146(9):831. https:\/\/doi.org\/10.1001\/jamaoto.2020.1453","journal-title":"JAMA Otolaryngol Neck Surg"},{"issue":"3","key":"9540_CR3","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","volume":"9","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP (2021) Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 9(3):1133\u20131141. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.063","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10209","key":"9540_CR4","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394(10209):1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"issue":"12","key":"9540_CR5","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/all.13875","volume":"74","author":"WJ Fokkens","year":"2019","unstructured":"Fokkens WJ, Lund V, Bachert C et al (2019) EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 74(12):2312\u20132319. https:\/\/doi.org\/10.1111\/all.13875","journal-title":"Allergy"},{"key":"9540_CR6","doi-asserted-by":"publisher","unstructured":"Fokkens WJ, Viskens AS, Backer V et al (2023) EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023. Rhinol J 0(0). https:\/\/doi.org\/10.4193\/Rhin22.489","DOI":"10.4193\/Rhin22.489"},{"issue":"5","key":"9540_CR7","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.jaci.2006.09.005","volume":"118","author":"EO Meltzer","year":"2006","unstructured":"Meltzer EO, Hamilos DL, Hadley JA et al (2006) Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118(5):S17\u2013S61. https:\/\/doi.org\/10.1016\/j.jaci.2006.09.005","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"9540_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.14639\/0392-100X-N0364","volume":"40","author":"S Gallo","year":"2020","unstructured":"Gallo S, Russo F, Mozzanica F et al (2020) Prognostic value of the sinonasal outcome test 22 (SNOT-22) in chronic rhinosinusitis. Acta Otorhinolaryngol Ital 40(2):113\u2013121. https:\/\/doi.org\/10.14639\/0392-100X-N0364","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9540_CR9","doi-asserted-by":"crossref","unstructured":"Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) Sniffin sticks\u2019: olfactory performance assessed by the combined testing of odor identification, Odor Discrimination and Olfactory Threshold","DOI":"10.1037\/t58174-000"},{"issue":"4","key":"9540_CR10","first-page":"183","volume":"31","author":"VJ Lund","year":"1993","unstructured":"Lund VJ, Mackay IS (1993) Staging in rhinosinusitus. Rhinology 31(4):183\u2013184","journal-title":"Rhinology"},{"key":"9540_CR11","unstructured":"Widal F, Abrami P, Lermoyez J (1987) First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By, Widal F, Abrami P, Lermoyez J (1987) J Asthma Off J Assoc Care Asthma 24(5):297\u2013300"},{"key":"9540_CR12","doi-asserted-by":"publisher","unstructured":"Reale M, Licci G, Orlando P et al (2024) Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. Eur Arch Otorhinolaryngol Published Online May 19. https:\/\/doi.org\/10.1007\/s00405-024-08725-7","DOI":"10.1007\/s00405-024-08725-7"},{"issue":"1","key":"9540_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40463-022-00570-0","volume":"51","author":"SJ Kilty","year":"2022","unstructured":"Kilty SJ, Lasso A (2022) Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps. J Otolaryngol - Head Neck Surg 51(1):17. https:\/\/doi.org\/10.1186\/s40463-022-00570-0","journal-title":"J Otolaryngol - Head Neck Surg"},{"issue":"1","key":"9540_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13223-023-00782-7","volume":"19","author":"E Grose","year":"2023","unstructured":"Grose E, Li AY, Lee JM (2023) Clinical outcomes of dupilumab therapy in chronic rhinosinusitis with nasal polyps in a Canadian tertiary care rhinology practice. Allergy Asthma Clin Immunol 19(1):26. https:\/\/doi.org\/10.1186\/s13223-023-00782-7","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"9540_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00405-022-07679-y","volume":"280","author":"F Jansen","year":"2023","unstructured":"Jansen F, Becker B, Eden JK et al (2023) Dupilumab (Dupixent\u00ae) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany. Eur Arch Otorhinolaryngol 280(4):1741\u20131755. https:\/\/doi.org\/10.1007\/s00405-022-07679-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"9540_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4193\/Rhin22.469","volume":"61","author":"R Boscke","year":"2023","unstructured":"Boscke R, Heidemann M, Bruchhage KL (2023) Dupilumab for chronic rhinosinusitis with nasal polyps: real-life retrospective 12-month effectiveness data. Rhinology 61(3):203\u2013213. https:\/\/doi.org\/10.4193\/Rhin22.469","journal-title":"Rhinology"},{"issue":"10","key":"9540_CR17","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/all.15772","volume":"78","author":"E De Corso","year":"2023","unstructured":"De Corso E, Pasquini E, Trimarchi M et al (2023) Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational phase IV real-life study (DUPIREAL). Allergy 78(10):2669\u20132683. https:\/\/doi.org\/10.1111\/all.15772","journal-title":"Allergy"},{"issue":"4","key":"9540_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/ph16040630","volume":"16","author":"C Galletti","year":"2023","unstructured":"Galletti C, Barbieri MA, Ciodaro F et al (2023) Effectiveness and safety profile of dupilumab in chronic rhinosinusitis with nasal polyps: Real-Life data in tertiary care. Pharmaceuticals 16(4):630. https:\/\/doi.org\/10.3390\/ph16040630","journal-title":"Pharmaceuticals"},{"issue":"5","key":"9540_CR19","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.waojou.2023.100780","volume":"16","author":"T Albrecht","year":"2023","unstructured":"Albrecht T, Sailer MM, Capitani F, Van Schaik C, L\u00f6wenheim H, Becker S (2023) Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy. World Allergy Organ J 16(5):100780. https:\/\/doi.org\/10.1016\/j.waojou.2023.100780","journal-title":"World Allergy Organ J"},{"issue":"5","key":"9540_CR20","doi-asserted-by":"publisher","first-page":"103927","DOI":"10.1016\/j.amjoto.2023.103927","volume":"44","author":"G Pecorari","year":"2023","unstructured":"Pecorari G, Piazza F, Borgione M et al (2023) The role of intranasal corticosteroids in chronic rhinosinusitis with nasal polyposis treated with dupilumab. Am J Otolaryngol 44(5):103927. https:\/\/doi.org\/10.1016\/j.amjoto.2023.103927","journal-title":"Am J Otolaryngol"},{"issue":"45","key":"9540_CR21","doi-asserted-by":"publisher","first-page":"e31031","DOI":"10.1097\/MD.0000000000031031","volume":"101","author":"M Bertlich","year":"2022","unstructured":"Bertlich M, Freytag S, Dombrowski T et al (2022) Subgroups in the treatment of nasal polyposis with dupilumab: A retrospective study. Med (Baltim) 101(45):e31031. https:\/\/doi.org\/10.1097\/MD.0000000000031031","journal-title":"Med (Baltim)"},{"issue":"1","key":"9540_CR22","doi-asserted-by":"publisher","first-page":"s40463","DOI":"10.1186\/s40463-023-00663-4","volume":"52","author":"NJ Campion","year":"2023","unstructured":"Campion NJ, Brugger J, Tu A et al (2023) The real life efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP. J Otolaryngol - Head Neck Surg 52(1):s40463. 023-00663-00664","journal-title":"J Otolaryngol - Head Neck Surg"},{"issue":"3","key":"9540_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00405-023-08309-x","volume":"281","author":"P Orlando","year":"2024","unstructured":"Orlando P, Licci G, Kuitche D et al (2024) Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report. Eur Arch Otorhinolaryngol 281(3):1317\u20131324. https:\/\/doi.org\/10.1007\/s00405-023-08309-x","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"9540_CR24","doi-asserted-by":"publisher","first-page":"e2023227","DOI":"10.23750\/abm.v94i5.14745","volume":"94","author":"G Bellocchi","year":"2023","unstructured":"Bellocchi G, Loperfido A, Passali FM et al (2023) Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: a multicentric study. Acta Biomed Atenei Parm 94(5):e2023227. https:\/\/doi.org\/10.23750\/abm.v94i5.14745","journal-title":"Acta Biomed Atenei Parm"},{"issue":"10","key":"9540_CR25","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1016\/j.jaip.2023.07.038","volume":"11","author":"IL Schmale","year":"2023","unstructured":"Schmale IL, Poulakis A, Abend A, Luitje ME, Man LX (2023) Chronic rhinosinusitis with nasal polyposis treated with dupilumab: Real-World use and outcomes. J Allergy Clin Immunol Pract 11(10):3203\u20133210. https:\/\/doi.org\/10.1016\/j.jaip.2023.07.038","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"9540_CR26","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1111\/all.15796","volume":"78","author":"RJL van der Lans","year":"2023","unstructured":"van der Lans RJL, Otten JJ, Adriaensen GFJPM et al (2023) Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy 78(10):2684\u20132697. https:\/\/doi.org\/10.1111\/all.15796","journal-title":"Allergy"},{"issue":"6","key":"9540_CR27","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1002\/lary.31238","volume":"134","author":"F Giombi","year":"2024","unstructured":"Giombi F, Pace GM, Nappi E et al (2024) Radiological versus clinical 1-Year outcomes of dupilumab in refractory crswnp: A Real-Life study. Laryngoscope 134(6):2626\u20132633. https:\/\/doi.org\/10.1002\/lary.31238","journal-title":"Laryngoscope"},{"issue":"9","key":"9540_CR28","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","volume":"66","author":"D Hastan","year":"2011","unstructured":"Hastan D, Fokkens WJ, Bachert C et al (2011) Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study: chronic rhinosinusitis in Europe. Allergy 66(9):1216\u20131223. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02646.x","journal-title":"Allergy"},{"issue":"5","key":"9540_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/all.12577","volume":"70","author":"JB Shi","year":"2015","unstructured":"Shi JB, Fu QL, Zhang H et al (2015) Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven C Hinese cities. Allergy 70(5):533\u2013539. https:\/\/doi.org\/10.1111\/all.12577","journal-title":"Allergy"},{"issue":"2","key":"9540_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4193\/Rhino11.256","volume":"50","author":"RR Pilan","year":"2012","unstructured":"Pilan RR, Pinna FR, Bezerra TF et al (2012) Prevalence of chronic rhinosinusitis in Sao Paulo. Rhinol J 50(2):129\u2013138. https:\/\/doi.org\/10.4193\/Rhino11.256","journal-title":"Rhinol J"},{"issue":"1","key":"9540_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino12.000","volume":"50","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J et al (2012) EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinol J 50(1):1\u201312. https:\/\/doi.org\/10.4193\/Rhino12.000","journal-title":"Rhinol J"},{"issue":"4","key":"9540_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565\u2013572. https:\/\/doi.org\/10.1016\/j.jaip.2016.04.012","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"9540_CR33","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1017\/S0022215107001302","volume":"122","author":"NY Busaba","year":"2008","unstructured":"Busaba NY, Sin HJ, Salman SD (2008) Impact of gender on clinical presentation of chronic rhinosinusitis with and without polyposis. J Laryngol Otol 122(11):1180\u20131184. https:\/\/doi.org\/10.1017\/S0022215107001302","journal-title":"J Laryngol Otol"},{"issue":"7","key":"9540_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/lary.20239","volume":"119","author":"JM Bernstein","year":"2009","unstructured":"Bernstein JM, Anon JB, Rontal M, Conroy J, Wang C, Sucheston L (2009) Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. Laryngoscope 119(7):1258\u20131264. https:\/\/doi.org\/10.1002\/lary.20239","journal-title":"Laryngoscope"},{"key":"9540_CR35","doi-asserted-by":"crossref","unstructured":"Ference EH, Tan BK, Hulse KE et al (2015) Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. Allergy Rhinol 6(2):e82\u2013e88","DOI":"10.2500\/ar.2015.6.0120"},{"key":"9540_CR36","doi-asserted-by":"publisher","unstructured":"Orlandi RR, Kingdom TT, Hwang PH et al (2016) International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol 6(S1). https:\/\/doi.org\/10.1002\/alr.21695","DOI":"10.1002\/alr.21695"},{"key":"9540_CR37","doi-asserted-by":"publisher","unstructured":"Mullol J, Langdon C (n.d.) Nasal polyps in patients with asthma: prevalence, impact, and management challenges. J Asthma Allergy Published Online March 2016:45. https:\/\/doi.org\/10.2147\/JAA.S86251","DOI":"10.2147\/JAA.S86251"},{"issue":"4","key":"9540_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","volume":"5","author":"WW Stevens","year":"2017","unstructured":"Stevens WW, Peters AT, Hirsch AG et al (2017) Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and Aspirin-Exacerbated respiratory disease. J Allergy Clin Immunol Pract 5(4):1061\u20131070e3. https:\/\/doi.org\/10.1016\/j.jaip.2016.12.027","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"9540_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12931-018-0823-y","volume":"19","author":"CM Philpott","year":"2018","unstructured":"On behalf of the CRES group, Philpott CM, Erskine S et al (2018) Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National chronic rhinosinusitis epidemiology study. Respir Res 19(1):129. https:\/\/doi.org\/10.1186\/s12931-018-0823-y","journal-title":"Respir Res"},{"issue":"4","key":"9540_CR40","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/lary.30983","volume":"134","author":"M Alicandri-Ciufelli","year":"2024","unstructured":"Alicandri-Ciufelli M, Marchioni D, Pipolo C et al (2024) Influence of prior endoscopic sinus surgery extent on dupilumab effectiveness in CRSwNP patients. Laryngoscope 134(4):1556\u20131563. https:\/\/doi.org\/10.1002\/lary.30983","journal-title":"Laryngoscope"},{"issue":"5","key":"9540_CR41","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00405-023-08417-8","volume":"281","author":"E De Corso","year":"2024","unstructured":"De Corso E, Montuori C, Baroni S et al (2024) Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study. Eur Arch Otorhinolaryngol 281(5):2429\u20132440. https:\/\/doi.org\/10.1007\/s00405-023-08417-8","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"9540_CR42","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/bjd.18434","volume":"182","author":"A Wollenberg","year":"2020","unstructured":"Wollenberg A, Beck LA, Blauvelt A et al (2020) Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS). Br J Dermatol 182(5):1120\u20131135. https:\/\/doi.org\/10.1111\/bjd.18434","journal-title":"Br J Dermatol"},{"issue":"1","key":"9540_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/cea.14153","volume":"53","author":"A Matucci","year":"2023","unstructured":"Matucci A, Nencini F, Maggiore G et al (2023) High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients. Clin Exp Allergy 53(1):78\u201387. https:\/\/doi.org\/10.1111\/cea.14153","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"9540_CR44","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1007\/s00405-022-07389-5","volume":"279","author":"A Vinciguerra","year":"2022","unstructured":"Vinciguerra A, Rampi A, Yacoub MR et al (2022) Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results. Eur Arch Otorhinolaryngol 279(11):5231\u20135238. https:\/\/doi.org\/10.1007\/s00405-022-07389-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9540_CR45","doi-asserted-by":"publisher","unstructured":"Govoni M, Soncini A, Bardon ML, Pasanisi E, Oretti G (2024) Dupilumab in chronic rhinosinusitis with nasal polyposis and concomitant cystic fibrosis: a real-life experience. Eur Arch Otorhinolaryngol Published Online Dec 7. https:\/\/doi.org\/10.1007\/s00405-024-09125-7","DOI":"10.1007\/s00405-024-09125-7"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09540-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:31:23Z","timestamp":1757226683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09540-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["9540"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09540-4","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interests regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}